JP2025500404A5 - - Google Patents
Info
- Publication number
- JP2025500404A5 JP2025500404A5 JP2024537875A JP2024537875A JP2025500404A5 JP 2025500404 A5 JP2025500404 A5 JP 2025500404A5 JP 2024537875 A JP2024537875 A JP 2024537875A JP 2024537875 A JP2024537875 A JP 2024537875A JP 2025500404 A5 JP2025500404 A5 JP 2025500404A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- structural formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293583P | 2021-12-23 | 2021-12-23 | |
| US63/293,583 | 2021-12-23 | ||
| PCT/US2022/053738 WO2023122228A1 (en) | 2021-12-23 | 2022-12-21 | Novel auristatin analogs and immunoconjugates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500404A JP2025500404A (ja) | 2025-01-09 |
| JP2025500404A5 true JP2025500404A5 (https=) | 2026-01-06 |
Family
ID=86903604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537875A Pending JP2025500404A (ja) | 2021-12-23 | 2022-12-21 | 新規オーリスタチン類似体およびその免疫複合体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250049937A1 (https=) |
| EP (1) | EP4453000A4 (https=) |
| JP (1) | JP2025500404A (https=) |
| KR (1) | KR20240152826A (https=) |
| CN (1) | CN118829645A (https=) |
| AU (1) | AU2022422015A1 (https=) |
| CA (1) | CA3241878A1 (https=) |
| IL (1) | IL313784A (https=) |
| TW (1) | TW202328162A (https=) |
| WO (1) | WO2023122228A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025067221A1 (zh) * | 2023-09-26 | 2025-04-03 | 上海齐鲁制药研究中心有限公司 | 奥瑞他汀衍生物及其抗体药物偶联物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015017552A1 (en) * | 2013-08-01 | 2015-02-05 | Agensys, Inc. | Antibody drug conjugates (adc) that bind to cd37 proteins |
| CA2951368A1 (en) * | 2014-06-13 | 2015-12-17 | Novartis Ag | Auristatin derivatives and conjugates thereof |
| CA3205824A1 (en) * | 2014-10-09 | 2016-04-14 | Genzyme Corporation | Glycoengineered antibody drug conjugates |
| US20190194315A1 (en) * | 2015-06-17 | 2019-06-27 | Novartis Ag | Antibody drug conjugates |
| CN119241554A (zh) * | 2017-12-15 | 2025-01-03 | 四川科伦博泰生物医药股份有限公司 | 生物活性物偶联物及其制备方法和用途 |
-
2022
- 2022-12-21 CA CA3241878A patent/CA3241878A1/en active Pending
- 2022-12-21 EP EP22912460.7A patent/EP4453000A4/en active Pending
- 2022-12-21 US US18/713,436 patent/US20250049937A1/en active Pending
- 2022-12-21 WO PCT/US2022/053738 patent/WO2023122228A1/en not_active Ceased
- 2022-12-21 KR KR1020247023535A patent/KR20240152826A/ko active Pending
- 2022-12-21 AU AU2022422015A patent/AU2022422015A1/en active Pending
- 2022-12-21 JP JP2024537875A patent/JP2025500404A/ja active Pending
- 2022-12-21 CN CN202280092301.4A patent/CN118829645A/zh active Pending
- 2022-12-21 IL IL313784A patent/IL313784A/en unknown
- 2022-12-22 TW TW111149562A patent/TW202328162A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3044898C (en) | Di-substituted maleic amide linker for antibody-drug conjugating and preparation method and use thereof | |
| CA1301066C (en) | Anti-tumour substance and process for producing the same | |
| JP2023089195A (ja) | グリピカン３抗体およびそのコンジュゲート | |
| TW202010498A (zh) | 喜樹鹼肽結合物 | |
| JP7465347B2 (ja) | 抗ｃ－Ｍｅｔ抗体薬物複合体 | |
| IL312845B2 (en) | Extacan derivatives, charge-linkers, and their conjugates | |
| JP6957629B2 (ja) | 非線状自壊性リンカーおよびそのコンジュゲート | |
| KR20140139480A (ko) | 항체-약물 접합체 및 관련 화합물, 조성물, 및 방법 | |
| JP2025509286A5 (https=) | ||
| EA010508B1 (ru) | Способ прицельного воздействия на определенные популяции клеток с помощью конъюгатов из майтансиноида и агента клеточного связывания, соединенных через нерасщепляемый линкер, конъюгаты и способы получения таких конъюгатов | |
| JP2021121590A5 (https=) | ||
| JP2022512830A5 (https=) | ||
| JP6321687B2 (ja) | アマトキシン誘導体 | |
| JP2024037776A5 (https=) | ||
| JP2025500404A5 (https=) | ||
| WO2024227439A1 (zh) | 具有靶向作用的偶联物及其制备方法和用途 | |
| JP2022546110A5 (https=) | ||
| JP2024540402A5 (https=) | ||
| JPH07223969A (ja) | チオエーテル結合体の製造法 | |
| TW201919711A (zh) | 預防免疫結合物中之甲硫胺酸氧化之方法 | |
| RU2004128465A (ru) | Ингибиторы фарнезилпротеинтрансферазы как противоопухолевые агенты | |
| JP2023512228A5 (https=) | ||
| CZ161288A3 (en) | Immunoglobulin conjugate, process of its preparation and pharmaceutical composition containing thereof | |
| JP2022521474A5 (https=) | ||
| JP2024532677A5 (https=) |